A Phase 1b/2 Study of Oral Nanatinostat (N) and Valganciclovir (Vg) in Subjects With Epstein-Barr Virus (Ebv)-Associated Lymphomas

Hematological Oncology - United Kingdom
doi 10.1002/hon.148_2630
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Epstein-Barr Virus (EBV)-associated Haemophagocytic Syndrome

Mediterranean Journal of Hematology and Infectious Diseases
Infectious DiseasesHematology
2012English

Pathogenic Role of Exosomes in Epstein-Barr Virus (EBV)-Associated Cancers

International Journal of Biological Sciences
Applied MicrobiologyEvolutionEcologyDevelopmental BiologyCell BiologyMolecular BiologySystematicsBehaviorBiotechnology
2017English

Epstein-Barr Virus (EBV) DNA in Sera of Patients With Primary EBV Infection

Journal of Clinical Microbiology
Microbiology
2001English

Immunoregulatory Defects and Epstein-Barr Virus (Ebv) in Hemophilia

Pediatric Research
Child HealthPediatricsPerinatology
1984English

Opportunities to Target the Life Cycle of Epstein-Barr Virus (EBV) in EBV-Associated Lymphoproliferative Disorders

Frontiers in Oncology
Cancer ResearchOncology
2019English

Association Between Epstein - Barr Virus (EBV) and Breast Cancer

Research in Molecular Medicine
2014English

PI3Kδ Inhibition Augments the Efficacy of Rapamycin in Suppressing Proliferation of Epstein−Barr Virus (EBV)+ B Cell Lymphomas

American Journal of Transplantation
TransplantationAllergyImmunologyPharmacology
2013English

Epstein-Barr Virus (EBV) Infection in Chinese Children: A Retrospective Study of Age-Specific Prevalence

PLoS ONE
Multidisciplinary
2014English

Sinonasal Lymphomas in Indonesia: Immunophenotype and Epstein-Barr Virus Association

Medical Journal of Indonesia
Medicine
2004English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy